Insights On Drug Development

  1. Meet Aggressive Timelines By Simplifying Your Drug Delivery Supply Chain 1/10/2020

    To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route for drug substance, drug product, and clinical trial packaging needs.

  2. Advanced Analytical Tools For Drug Product Development 12/23/2019

    Gain insight into analytical techniques that reveal answers during product development, with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS).

  3. A Roadmap For Early Development To Commercial Manufacturing 12/23/2019

    A key hurdle for any drug development program is bringing the drug to clinical studies. In this webcast, industry experts have presented  key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.

  4. The Next Generation ODT 12/20/2019

    Orally dissolving tablets (ODT) are designed to dissolve rapidly on contact with saliva, therefore eliminating the need to chew the tablet, swallow the intact tablet, or take the tablet with liquids. Zydis® ODT fast-dissolve formulation from Catalent is a unique, freeze-dried tablet that disperses instantly in the mouth in less than three seconds. View the webinar to get an overview of the Zydis ODT technology, including new ways to administer peptides and vaccines. The webinar also presents the highlights of the next generation ODT technology, Zydis Ultra which can provide a better solution in terms of improved taste masking, innovative functional coating and a wide range of applications from Rx to OTC.

  5. Zydis® Bio Technology, Grazax® & Grastek®: Revolutionizing Allergy Therapy 12/18/2019

    ALK-Abelló is a global research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. Before ALK-Abelló partnered with Catalent, all marketed allergen immunotherapies were delivered by injection, resulting in a limited patient population and reduced patient adherence. Catalent worked with the client to apply Zydis Fast Dissolve Technology to their therapy, bringing a vastly superior product to market.

  6. LV Scale-Up Workflow In Single-Use Bioreactors For GMP Compliance 11/8/2019

    Cost-effective manufacturing of lentiviral vectors (LV) at commercial scales has proven difficult and remains a pressing issue for the marketing of therapies that depend on their application.

  7. Quality Matters – SEC Analysis For Antibody Aggregates 10/25/2019

    Size exclusion chromatography is the go-to analytical method for therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

  8. Kaleido Biosciences Successfully Meets Aggressive IND Filing Thanks To Strategic Partnership 10/8/2019

    Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager.

  9. Managing The Challenges Of Small Batch Formulations 10/3/2019

    A risk-based investment in understanding GMP manufacturing at small scales can prevent costly issues during scaling development that ultimately affect the timely delivery to patients in need.

  10. Is Your Complex Formulation Process Set Up For Success? 10/1/2019

    Any company pursuing a drug delivery system that involves a complex formulation must be prepared for the requirements around this type of drug development to achieve successful scale-up.